Role of multiparametric magnetic resonance imaging (MRI) in focal therapy for prostate cancer: A Delphi consensus project

BJU International

Volumn 114, Issue 5, 2014, Pages 698-707

  Muller, Berrend G ^a   Van Den Bos, Willemien ^a   Brausi, Maurizio ^b   Cornud, Francois ^c   Gontero, Paolo ^d   Kirkham, Alexander ^e   Pinto, Peter A ^f   Polascik, Thomas J ^g   Rastinehad, Ardeshir R ^h   De Reijke, Theo M ^a   De La Rosette, Jean J ^a   Ukimura, Osamu ⁱ   Villers, Arnauld ^j   Walz, Jochen ^k   Wijkstra, Hessel ^a,l   Marberger, Michael ^m  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Nuovo Ospedale S Agostino   (Italy)

^c Cochin Hospital ^*  (France)

^d MOLINETTE HOSPITAL   (Italy)

^e UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^f NATIONAL CANCER INSTITUTE   (United States)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

^h New Hyde Park   (United States)

ⁱ UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^j UNIV LILLE   (France)

^k INSTITUT PAOLI CALMETTES   (France)

^l EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^m MEDICAL UNIVERSITY OF VIENNA   (Austria)

more..

Author keywords

consensus; focal therapy; multiparametric MRI; prostate cancer

Indexed keywords

ARTICLE; CANCER THERAPY; CLINICAL PROTOCOL; CONTRAST ENHANCEMENT; CRYOTHERAPY; DELPHI STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHOGRAPHY; ELECTROPORATION; FOCAL THERAPY; FOLLOW UP; GLEASON SCORE; HIGH INTENSITY FOCUSED ULTRASONOGRAPHY; HUMAN; IMAGE ANALYSIS; IRREVERSIBLE ELECTROPORATION; LOW LEVEL LASER THERAPY; MALE; MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING; NITROGEN NUCLEAR MAGNETIC RESONANCE; OUTCOME ASSESSMENT; PATIENT MONITORING; PATIENT SELECTION; PHOTODYNAMIC THERAPY; PROSTATE BIOPSY; PROSTATE CANCER; QUESTIONNAIRE; RADIOFREQUENCY ABLATION; RADIOLOGIST; STANDARDIZATION; TREATMENT PLANNING; TUMOR LOCALIZATION; UROLOGIST; ABLATION THERAPY; CONSENSUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; PROSTATIC NEOPLASMS;

ABLATION TECHNIQUES; CONSENSUS; DELPHI TECHNIQUE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PROSTATIC NEOPLASMS; QUESTIONNAIRES;

EID: 84912525328     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12548     Document Type: Article

References (28)

1. Obenauer S, Hermann KP, Grabbe E,. Applications and literature review of the BI-RADS classification. Eur Radiol 2005; 15: 1027-1036
2. Roche NA, Given-Wilson RM, Thomas VA, Sacks NP,. Assessment of a scoring system for breast imaging. Br J Surg 1998; 85: 669-672
3. Maxwell AJ, Ridley NT, Rubin G, Wallis MG, Gilbert FJ, Michell MJ,. The Royal College of Radiologists Breast Group breast imaging classification. Clin Radiol 2009; 64: 624-627
4. McLaughlin SA,. Surgical management of the breast: breast conservation therapy and mastectomy. Surg Clin North Am 2013; 93: 411-428
5. Heidenreich A, Bellmunt J, Bolla M, et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol 2011; 59: 61-71
6. Polascik TJ, Mayes JM, Sun L, Madden JF, Moul JW, Mouraviev V,. Pathologic stage T2a and T2b prostate cancer in the recent prostate-specific antigen era: implications for unilateral ablative therapy. Prostate 2008; 68: 1380-1386
7. Eggener S, Salomon G, Scardino PT, De la Rosette J, Polascik TJ, Brewster S,. Focal therapy for prostate cancer: possibilities and limitations. Eur Urol 2010; 58: 57-64
8. Tsivian M, Polascik TJ,. Focal cryotherapy for prostate cancer. Curr Urol Rep 2010; 11: 147-151
9. Cordeiro ER, Cathelineau X, Thüroff S, Marberger M, Crouzet S, de la Rosette JJMCH,. High-intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer. BJU Int 2012; 110: 1228-1242
10. Oto A, Sethi I, Karczmar G, et al. MR imaging-guided focal laser ablation for prostate cancer: phase I trial. Radiology 2013; 267: 932-940
11. Patriarca C, Bergamaschi F, Gazzano G, et al. Histopathological findings after radiofrequency (RITA) treatment for prostate cancer. Prostate Cancer Prostatic Dis 2006; 9: 266-269
12. Onik G, Mikus P, Rubinsky B,. Irreversible electroporation: implications for prostate ablation. Technol Cancer Res Treat 2007; 6: 295-300
13. Moore CM, Emberton M, Bown SG,. Photodynamic therapy for prostate cancer-an emerging approach for organ-confined disease. Lasers Surg Med 2011; 43: 768-775
14. Gupta RT, Kauffman CR, Polascik TJ, Taneja SS, Rosenkrantz AB,. The state of prostate MRI in 2013. Oncology (Williston Park) 2013; 27: 262-270
15. Kirkham APS, Emberton M, Allen C,. How good is MRI at detecting and characterising cancer within the prostate? Eur Urol 2006; 50: 1163-1174; discussion 1175
16. Dickinson L, Ahmed HU, Allen C, et al. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol 2011; 59: 477-494
17. Moore CM, Kasivisvanathan V, Eggener S, et al. Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group. Eur Urol 2013; 64: 544-552
18. Barentsz JO, Richenberg J, Clements R, et al. ESUR prostate MR guidelines 2012. Eur Radiol 2012; 22: 746-757
19. Hsu C, Sandford B,. The Delphi technique: making sense of consensus. Pract Assess Res Eval 2007; 12: 1-8
20. Linstone HA,. The Delphi Method, 2002nd edn. Reading, MA: Addison-Wesley, 1975
21. Yousuf M,. Using experts' opinions through Delphi technique. Pract Assess Res Eval 2007; 12: 1-8
22. Bratan F, Niaf E, Melodelima C, et al. Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study. Eur Radiol 2013; 23: 2019-2029
23. Turkbey B, Mani H, Shah V, et al. Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. J Urol 2011; 186: 1818-1824
24. Ramsay E, Mougenot C, Köhler M, et al. MR thermometry in the human prostate gland at 3.0T for transurethral ultrasound therapy. J Magn Reson Imaging 2013; 38: 1-8
25. Fiard G, Hohn N, Descotes J-L, Rambeaud J-J, Troccaz J, Long J-A,. Targeted MRI-guided prostate biopsies for the detection of prostate cancer: initial clinical experience with real-time 3-dimensional transrectal ultrasound guidance and magnetic resonance/transrectal ultrasound image fusion. Urology 2013; 81: 1372-1378
26. Hutchings A, Raine R,. A systematic review of factors affecting the judgments produced by formal consensus development methods in health care. J Health Serv Res Policy 2006; 11: 172-179
27. Ahmed HU, Kirkham A, Arya M, et al. Is it time to consider a role for MRI before prostate biopsy? Nat Rev Clin Oncol 2009; 6: 197-206
28. Nelson AW, Harvey RC, Parker RA, Kastner C, Doble A, Gnanapragasam VJ,. Repeat prostate biopsy strategies after initial negative biopsy: meta-regression comparing cancer detection of transperineal, transrectal saturation and MRI guided biopsy. PloS One 2013; 8: e57480